Atlas Trials

Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI

Clinical trial NCT06277674 · UNKNOWN

Trial details

NCT number
NCT06277674
Sponsor
Guangzhou University of Traditional Chinese Medicine
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2023-11-02
Primary completion
2024-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.